Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Mar 17, 2017, 08:00 ET First dedicated outcome trials of empagliflozin in chronic heart failure initiated

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that the EMPEROR HF clinical trial program was initiated. EMPEROR HF...


Mar 17, 2017, 07:00 ET Resverlogix Announces Third Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone and Provides an Update on Corporate Activities

A data review by the independent Data Safety Monitoring Board resulted in a recommendation for the BETonMACE trial to continue as planned without...


Mar 17, 2017, 03:01 ET Degree of Spinal Deformity Affects Hip Replacement Surgery Success

People with spinal deformity also requiring a total hip replacement are at greater risk for dislocation or follow-up revision surgery, suggesting...


Mar 17, 2017, 02:10 ET Nordic Nanovector Announces First Patient Dosed in Phase 1 Study of Betalutin® in Diffuse Large B-cell Lymphoma (DLBCL), an Aggressive Form of NHL

Nordic Nanovector ASA (OSE: NANO) announces that the first patient has been dosed in its Phase 1 study evaluating Betalutin®...


Mar 16, 2017, 16:05 ET aTyr Pharma Announces Fourth Quarter and Year-End 2016 Operating Results

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address...


Mar 16, 2017, 15:25 ET Mezzi di contrasto a base di gadolinio: aggiornamento sulle raccomandazioni del PRAC

Guerbet (FR0000032526 GBT), specialista globale nel campo dei mezzi di contrasto e delle soluzioni per l'imaging, ha preso atto oggi delle...


Mar 16, 2017, 10:48 ET Magellan Diagnostics and PDXWildlife Partner to Identify Lead Exposure in Giant Pandas

Magellan Diagnostics, the maker of a point-of-care blood lead analyzer, has announced an agreement to provide its LeadCare® II testing system to...


Mar 16, 2017, 10:37 ET Proove® Biosciences Presents Precision Medicine Research On Pain Medications At 2017 American Academy Of Pain Medicine Annual Meeting

Proove® Biosciences, Inc. is presenting industry-leading research in precision pain medicine this week at the 2017 Annual Meeting of the American...


Mar 16, 2017, 10:00 ET An Important Recognition in the US Market for the WatchPAT™ Device: The American Academy of Sleep Medicine ("AASM") has Formally Endorsed Itamar Medical's WatchPAT™ Technology to Diagnose Sleep Apnea, Based on Published Evidence

Itamar Medical Ltd. (TASE: ITMR) reports that AASM, the leading medical association of sleep medicine physicians in the United States, has...


Mar 16, 2017, 09:24 ET BioDelivery Sciences Announces Three Data Presentations on BELBUCA® at the American Academy of Pain Medicine 33rd Annual Meeting

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced three data presentations from research surrounding BELBUCA® (buprenorphine)...


Mar 16, 2017, 09:00 ET Kadimastem Granted a Patent in the US for Treatment of Neurodegenerative Diseases

Israeli biotechnology company Kadimastem (TASE: KDST), announced that it has been granted a patent from the United States Patent and Trademark...


Mar 16, 2017, 08:46 ET Kontrastmittel auf Gadolinium-Basis: Neueste Informationen zu PRAC-Empfehlungen

Guerbet (FR0000032526 GBT), ein globaler Spezialist für Kontrastmittel und -lösungen zur medizinischen Bildgebung gab heute die vom Ausschuss für...


Mar 16, 2017, 08:00 ET Mast Therapeutics Sets Date For Special Meeting Of Stockholders To Vote On Proposed Merger With Savara

Mast Therapeutics, Inc. (NYSE MKT: MSTX) announced today it has set a date for a special meeting of its stockholders to vote on matters related to...


Mar 16, 2017, 07:05 ET Biostage Promotes Saverio La Francesca, M.D. to President

Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat...


Mar 16, 2017, 07:00 ET Oncolytics Biotech® Inc. Enters into First-in-Class Collaboration with Myeloma UK and Celgene Using REOLYSIN® in Combination with Imnovid® or Revlimid® in Patients with Myeloma

CALGARY, March 16, 2017 /PRNewswire/ - Oncolytics Biotech® Inc. (Oncolytics or the Company) (TSX:ONC) (OTCQX:ONCYF) today announced that cancer...


Mar 16, 2017, 05:30 ET Vascular Graft Solutions beweist mit Vest-III-Studie ausgezeichnete Ergebnisse bei frühen Offenheitsraten und Sicherheitsprofil von extern stabilisierten Venengrafts

Vascular Graft Solutions (VGS) hat die Zwischenergebnisse von VEST III bekanntgegeben, eine randomisierte, kontrollierte Post-Market-Studie zum...


Mar 16, 2017, 03:01 ET Smoking Cessation Programs Benefit Patients Prior to Joint Replacements

Smokers who needed a hip or knee replacement experienced better surgical outcomes and fewer adverse events including hospital readmissions,...


Mar 16, 2017, 02:00 ET Shire Receives European Approval for Label Extension of CINRYZE®▼(C1 inhibitor [human]) to Prevent and Treat Hereditary Angioedema (HAE) Attacks in Paediatric Patients with HAE

CINRYZE is now the first and only Hereditary angioedema treatment approved for routine prevention in paediatrics Shire plc (LSE: SHP,...


Mar 15, 2017, 16:05 ET Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Study Evaluating JZP-258 for the Treatment of Cataplexy and Excessive Daytime Sleepiness in Narcolepsy

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a Phase 3 clinical study evaluating JZP-258, an...


Mar 15, 2017, 15:09 ET Innovative Cardiovascular Solutions Announces Successful First Cases in European Clinical Study of EMBLOK Embolic Protection System

Innovative Cardiovascular Solutions (ICS), a privately held medical device company pioneering novel solutions for embolic protection during...